Sanofi Sanofi has agreed a deal to buy out its partner, US biotech company Principia Biopharma for USD 3.7 billion in cash, giving the French giant full ownership of Principia’s pipeline of BTK inhibitors for autoimmune disorders. The deal, whereby Sanofi is set to pay USD 100 a share to…
See our Cookie Privacy Policy Here